WCN26-2911 DETERMINING OPTIMAL STRATEGY EMPLOYING ANTITHYMOCYTE GLOBULIN (DOSE-ATG) AS INDUCTION THERAPY AMONG FILIPINO KIDNEY TRANSPLANT RECIPIENTS: A RETROSPECTIVE COHORT

Read full text Summarise with VIRAT
Authors: WILMARK GULAR, Brian Michael I. Cabral, Mary Jane Cabuenos, Rachelle Dianne Ferry, Christia June Laparan
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

End-stage renal disease (ESRD) is one of the leading causes of morbidity and mortality worldwide. Kidney Transplant (KT) remains to be the gold standard for all renal replacement therapies for ESRD. The transplant process includes induction therapy with an immunosuppressant. One of the most widely used induction agents is rabbit antithymocyte globulin (rATG). Induction therapy is done to prevent acute rejection, which in effect prolongs allograft and patient survival. The study aimed to determine the mean cumulative dose of rATG induction therapy among Filipino kidney transplant recipients (KTRs).

Fields of Study & Subjects

Renal Transplantation Outcomes and Treatments Transplantation: Methods and Outcomes Organ Donation and Transplantation

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105460–105460
Publication date
25 March 2026
Language
EN